Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jun 11, 2021 6:23pm
58 Views
Post# 33376675

RE:RE:RE:RE:Short term cash is a problem unless they sell PRV ASAP

RE:RE:RE:RE:Short term cash is a problem unless they sell PRV ASAPI know its US currency, all my numbers are USD.  Man you are slow, no matter which ID you use.

So LMNL sold two weeks for $15M USD (two facilities), $5M USD (Ryplazim +) and will get $70M USD for voucher. $92M USD or $100M CDN as you like to chirp in with.

Had they sat on their hands as I said.  They would have kept the two facilities, kept Ryplazim and the revenue stream AND had the voucher worth $100M USD or $109M CDN. 

We gave up two collection facilities, Ryplazim and its revenue and accept less money for the voucher.

LMNL gave up the farm two weeks before FDA approval.  I know you won't understand this Stups but anyone thinking of investing will question this dumb move.



Newcamo wrote:

its u.s. currency dumbass,  so 100M$+ can.

:)

no more beer for u.

 

 

GunnerG wrote: LOL, they made a deal to sell two collection facilities, Ryplazim (their only revenue) and sold 30% of the voucher for $22M.

LMNL get 70% of the voucher when sold.  Should be about $70M coming from the voucher.  Thats a total of $92M.

Had LMNL just sat on their hands and not made this dumb deal two weeks before FDA approval, they would have had $100M, kept the two collection facilities and kept Ryplazim and its revenue stream.

This is the deal StupsNewcamo thinks is good.  Nothing left.


 

 

Newcamo wrote:

they just made a deal for 100M$ dude, are u ok stockbaboon?:)))

Newcamo (62)
June 11, 2021 - 12:05 PM
47 Reads
Post# 33372560

money not a problem anymore

with this FDA ok,  we can sell that riplazym voucher...market price is between 80M$-120M$ u.s., so lets say 100M$ u.s., we get 70%.... 70M$ u.s. + 17M$ u.s. we cashed already, around 100M$ can$ , lmnl will be able to execute big time and do more deals like this (sell or partner), we gat some in the oven already. Doyour dd. Dont listen to the clown$ operating on this board.  They are here for $$$... accumulation time....


 


 




<< Previous
Bullboard Posts
Next >>